“…However, Δ 9 -tetrahydrocannabinol (THC), the primary psychoactive compound in cannabis, is associated with psychotomimetic side effects and an increased risk of developing neuropsychiatric disorders in some individuals. Schizophrenia is characterized by disturbances in emotional salience attribution (Katthagen et al, 2016;Palaniyappan et al, 2013), neurocognitive sensory filtering (Wynn et al, 2004), memory abnormalities (Behrendt, 2016;Paz-Alonso et al, 2013) and heightened anxiety and paranoia (Buonocore et al, 2018;Morrison and Cohen, 2014). THC can induce these effects via its modulatory influence on mesocorticolimbic dopamine (DA) transmission and associated molecular signalling pathways (Bossong et al, 2015;Renard et al, 2017a,b).…”